BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 31615790)

  • 1. Clinical Factors Associated with Urinary Tract Cancer in Individuals with Lynch Syndrome.
    Wischhusen JW; Ukaegbu C; Dhingra TG; Uno H; Kastrinos F; Syngal S; Yurgelun MB
    Cancer Epidemiol Biomarkers Prev; 2020 Jan; 29(1):193-199. PubMed ID: 31615790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathological characteristics of patients with upper urinary tract urothelial cancer with loss of immunohistochemical expression of the DNA mismatch repair proteins in universal screening.
    Urakami S; Inoshita N; Oka S; Miyama Y; Nomura S; Arai M; Sakaguchi K; Kurosawa K; Okaneya T
    Int J Urol; 2018 Feb; 25(2):151-156. PubMed ID: 29164703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Familial Burden and Other Clinical Factors Associated With Various Types of Cancer in Individuals With Lynch Syndrome.
    Biller LH; Horiguchi M; Uno H; Ukaegbu C; Syngal S; Yurgelun MB
    Gastroenterology; 2021 Jul; 161(1):143-150.e4. PubMed ID: 33794268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary Tract Cancer in Lynch Syndrome; Increased Risk in Carriers of MSH2 Mutations.
    Joost P; Therkildsen C; Dominguez-Valentin M; Jönsson M; Nilbert M
    Urology; 2015 Dec; 86(6):1212-7. PubMed ID: 26385421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Factors Associated With Gastric Cancer in Individuals With Lynch Syndrome.
    Kim J; Braun D; Ukaegbu C; Dhingra TG; Kastrinos F; Parmigiani G; Syngal S; Yurgelun MB
    Clin Gastroenterol Hepatol; 2020 Apr; 18(4):830-837.e1. PubMed ID: 31319185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of Lynch syndrome among patients with upper urinary tract carcinoma in a Japanese hospital-based population.
    Ito T; Kono K; Eguchi H; Okazaki Y; Yamamoto G; Tachikawa T; Akagi K; Okada Y; Kawakami S; Morozumi M; Tamaru JI; Ishida H
    Jpn J Clin Oncol; 2020 Jan; 50(1):80-88. PubMed ID: 31665498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Excess of extracolonic non-endometrial multiple primary cancers in MSH2 germline mutation carriers over MLH1.
    Lin-Hurtubise KM; Yheulon CG; Gagliano RA; Lynch HT
    J Surg Oncol; 2013 Dec; 108(7):433-7. PubMed ID: 24122742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Universal screening for Lynch syndrome in endometrial cancers: frequency of germline mutations and identification of patients with Lynch-like syndrome.
    Dillon JL; Gonzalez JL; DeMars L; Bloch KJ; Tafe LJ
    Hum Pathol; 2017 Dec; 70():121-128. PubMed ID: 29107668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of mismatch repair-deficient crypt foci in Lynch syndrome: a pathological study.
    Kloor M; Huth C; Voigt AY; Benner A; Schirmacher P; von Knebel Doeberitz M; Bläker H
    Lancet Oncol; 2012 Jun; 13(6):598-606. PubMed ID: 22552011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The risk of extra-colonic, extra-endometrial cancer in the Lynch syndrome.
    Watson P; Vasen HFA; Mecklin JP; Bernstein I; Aarnio M; Järvinen HJ; Myrhøj T; Sunde L; Wijnen JT; Lynch HT
    Int J Cancer; 2008 Jul; 123(2):444-449. PubMed ID: 18398828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Commentary on "Risks of primary extracolonic cancers following colorectal cancer in Lynch syndrome." Win AK, Lindor NM, Young JP, Macrae FA, Young GP, Williamson E, Parry S, Goldblatt J, Lipton L, Winship I, Leggett B, Tucker KM, Giles GG, Buchanan DD, Clendenning M, Rosty C, Arnold J, Levine AJ, Haile RW, Gallinger S, Le Marchand L, Newcomb PA, Hopper JL, Jenkins MA, Centre for Molecular, Environmental, Genetic and Analytic Epidemiology, Melbourne School of Population Health, The University of Melbourne, Victoria, Australia: J Natl Cancer Inst 2012;104(18):1363-72 [Epub 2012 Aug 28].
    See WA
    Urol Oncol; 2013 Jul; 31(5):716. PubMed ID: 23796201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The spectrum of urological malignancy in Lynch syndrome.
    Barrow PJ; Ingham S; O'Hara C; Green K; McIntyre I; Lalloo F; Hill J; Evans DG
    Fam Cancer; 2013 Mar; 12(1):57-63. PubMed ID: 23054215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical factors associated with skin neoplasms in individuals with Lynch syndrome in a longitudinal observational cohort.
    Zhong CS; Horiguchi M; Uno H; Ukaegbu C; Chittenden A; LeBoeuf NR; Syngal S; Nambudiri VE; Yurgelun MB
    J Am Acad Dermatol; 2023 Jun; 88(6):1282-1290. PubMed ID: 36773823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type 2 diabetes mellitus, blood cholesterol, triglyceride and colorectal cancer risk in Lynch syndrome.
    Dashti SG; Li WY; Buchanan DD; Clendenning M; Rosty C; Winship IM; Macrae FA; Giles GG; Hardikar S; Hua X; Thibodeau SN; Figueiredo JC; Casey G; Haile RW; Gallinger S; Le Marchand L; Newcomb PA; Potter JD; Lindor NM; Hopper JL; Jenkins MA; Win AK
    Br J Cancer; 2019 Nov; 121(10):869-876. PubMed ID: 31551580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and Validation of the PREMM
    Kastrinos F; Uno H; Ukaegbu C; Alvero C; McFarland A; Yurgelun MB; Kulke MH; Schrag D; Meyerhardt JA; Fuchs CS; Mayer RJ; Ng K; Steyerberg EW; Syngal S
    J Clin Oncol; 2017 Jul; 35(19):2165-2172. PubMed ID: 28489507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk and epidemiological time trends of gastric cancer in Lynch syndrome carriers in the Netherlands.
    Capelle LG; Van Grieken NC; Lingsma HF; Steyerberg EW; Klokman WJ; Bruno MJ; Vasen HF; Kuipers EJ
    Gastroenterology; 2010 Feb; 138(2):487-92. PubMed ID: 19900449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The identification of Lynch syndrome in Congolese colorectal cancer patients.
    Poaty H; Aba Gandzion C; Soubeyran I; Gassaye D; Peko JF; Nkoua Bon JB; Gombé Mbalawa C
    Bull Cancer; 2017 Oct; 104(10):831-839. PubMed ID: 28988047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative diagnosis of Lynch syndrome with DNA mismatch repair immunohistochemistry on a diagnostic biopsy.
    Warrier SK; Trainer AH; Lynch AC; Mitchell C; Hiscock R; Sawyer S; Boussioutas A; Heriot AG
    Dis Colon Rectum; 2011 Dec; 54(12):1480-7. PubMed ID: 22067175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequency of rearrangements in Lynch syndrome cases associated with MSH2: characterization of a new deletion involving both EPCAM and the 5' part of MSH2.
    Pérez-Cabornero L; Infante Sanz M; Velasco Sampedro E; Lastra Aras E; Acedo Becares A; Miner Pino C; Durán Domínguez M
    Cancer Prev Res (Phila); 2011 Oct; 4(10):1556-62. PubMed ID: 21791569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined Microsatellite Instability, MLH1 Methylation Analysis, and Immunohistochemistry for Lynch Syndrome Screening in Endometrial Cancers From GOG210: An NRG Oncology and Gynecologic Oncology Group Study.
    Goodfellow PJ; Billingsley CC; Lankes HA; Ali S; Cohn DE; Broaddus RJ; Ramirez N; Pritchard CC; Hampel H; Chassen AS; Simmons LV; Schmidt AP; Gao F; Brinton LA; Backes F; Landrum LM; Geller MA; DiSilvestro PA; Pearl ML; Lele SB; Powell MA; Zaino RJ; Mutch D
    J Clin Oncol; 2015 Dec; 33(36):4301-8. PubMed ID: 26552419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.